Article info
Clinical and epidemiological research
Extended report
Nationwide prevalence of rheumatoid arthritis and penetration of disease-modifying drugs in Sweden
- Correspondence to Dr Martin Neovius, Clinical Epidemiology Unit (T2), Department of Medicine (Solna), Karolinska Institutet, SE-171 76 Stockholm, Sweden; Martin.Neovius{at}ki.se
Citation
Nationwide prevalence of rheumatoid arthritis and penetration of disease-modifying drugs in Sweden
Publication history
- Accepted November 1, 2010
- First published December 13, 2010.
Online issue publication
November 02, 2019
Article Versions
- Previous version (2 November 2019).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions